In a 4T1 BC model, rAd.sT significantly reduced tumor weight, inhibited lung metastasis, and downregulated angiogenesis- and metastasis-related genes such as VEGFA, CXCR-4, and E-cadherin. This evidence concerns the gene CXCR4 and neoplasm.